Nebula Research & Development LLC Bausch Health Companies Inc. Transaction History
Nebula Research & Development LLC
- $852 Billion
- Q4 2024
A detailed history of Nebula Research & Development LLC transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Nebula Research & Development LLC holds 33,024 shares of BHC stock, worth $236,121. This represents 0.03% of its overall portfolio holdings.
Number of Shares
33,024
Previous 56,100
41.13%
Holding current value
$236,121
Previous $458 Million
41.86%
% of portfolio
0.03%
Previous 0.05%
Shares
7 transactions
Others Institutions Holding BHC
# of Institutions
271Shares Held
252MCall Options Held
5.12MPut Options Held
9.43M-
Icahn Carl C Sunny Isles Beach, FL34.7MShares$248 Million3.8% of portfolio
-
Goldentree Asset Management LP New York, NY27.5MShares$197 Million16.77% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny26.4MShares$189 Million12.9% of portfolio
-
National Bank Of Canada15.4MShares$110 Million0.17% of portfolio
-
Healthcare Of Ontario Pension Plan Trust Fund Toronto, A613MShares$93 Million0.23% of portfolio
About Bausch Health Companies Inc.
- Ticker BHC
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 361,728,000
- Market Cap $2.59B
- Description
- Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...